Assessing potential health risks from microcystin toxins in blue-green algae dietary supplements

Citation
Dj. Gilroy et al., Assessing potential health risks from microcystin toxins in blue-green algae dietary supplements, ENVIR H PER, 108(5), 2000, pp. 435-439
Citations number
50
Categorie Soggetti
Environment/Ecology,"Pharmacology & Toxicology
Journal title
ENVIRONMENTAL HEALTH PERSPECTIVES
ISSN journal
00916765 → ACNP
Volume
108
Issue
5
Year of publication
2000
Pages
435 - 439
Database
ISI
SICI code
0091-6765(200005)108:5<435:APHRFM>2.0.ZU;2-H
Abstract
The presence of blue-green algae (EGA) toxins in surface waters used for dr inking water sources and recreation is receiving increasing attention aroun d the world as a public health concern. However, potential risks from expos ure to these toxins in contaminated health food products that contain EGA h ave been largely ignored. EGA products are commonly consumed in the United States, Canada, and Europe for their putative beneficial effects, including increased energy and elevated mood. Many of these products contain Aphaniz omenon flos-aquae, a EGA that is harvested from Upper Klamath Lake (UKL) in southern Oregon, where the growth of a toxic EGA, Microcystis aeruginosa, is a regular occurrence. M, aeruginosa produces compounds called microcysti ns, which are potent hepatotoxins and probable tumor promoters. Because M. aeruginosa coexists with A. flos-aquae, it can be collected inadvertently d uring the harvesting process, resulting in microcystin contamination of EGA products. In fall 1996, the Oregon Health Division learned that UKL was ex periencing an extensive M. aeruginosa bloom, and an advisory was issued rec ommending against water contact. The advisory prompted calls from consumers of EGA products, who expressed concern about possible contamination of the se products with microcystins. In response, the Oregon Health Division and the Oregon Department of Agriculture established a regulatory limit of 1 mu g/g for microcystins in EGA-containing products and tested EGA products fo r the presence of microcystins. Microcystins were detected in 85 of 87 samp les tested, with 63 samples (72%) containing concentrations > 1 mu g/g. HPL C and ELISA tentatively identified microcystin-1R, the most toxic microcyst in variant, as the predominant congener.